CVS Financial Facts
Net loss attributable to noncontrolling interest: -1MCost of revenues: 37.12B
See Full Income Statement
Total liabilities and shareholders' equity: 94.16B
Short-term debt: 340M
See Full Balance Sheet
CVS Caremark Corporation (CVS) Earnings
|
Expand Research on CVS
| Next EPS Date | 8/5/26 | EPS Growth Rate | +1.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.5% | Revenue Growth Rate | +1.2% |
| Average % Move 1-Wk after EPS | +4.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | $1.83 | N/A | N/A | $100.12B | = | N/A | N/A | ||
| 5/6/26 | Q126 | $2.57 | $2.21 | +$0.36 | $100.4B | $95.02B | = |  | | Details | |
| 2/10/26 | Q425 | $1.09 | $1.00 | +$0.09 | $105.7B | $103.63B | = | | | Details | |
| 10/29/25 | Q325 | $1.60 | $1.37 | +$0.23 | $102.9B | $98.88B | = | | | Details | |
| 7/31/25 | Q225 | $1.81 | $1.46 | +$0.35 | $98.9B | $94.73B | = | | | Details | |
| 5/1/25 | Q125 | $2.25 | $1.64 | +$0.61 | $94.6B | $93.07B | = | | | Details | |
| 2/12/25 | Q424 | $1.19 | $1.00 | +$0.19 | $97.7B | $96.97B | = | | | Details | |
| 11/6/24 | Q324 | $1.09 | $1.55 | -$0.46 | $95.4B | $92.7B |  |
| | Details |
